Drug development

The Role of High-Throughput Screening (HTS) in Cell Line Development and Process Optimization

Biologics, Drug development

Co-Development Partnership Models in Biologics Programs

Biologics, Drug development, Mabion, Partnership

Scaling Antibody Production for ADC Programs

Antibody-drug conjugates, Drug development, Manufacturing

Protein Characterization Techniques for Biologics Development

Analytics, Biosimilars, Drug development, Proteins

Upstream Development for High Yield Biologics Production 

Biologics, Drug development, Manufacturing

The New Era of Biosimilar Development: Seizing the Opportunity Under EMA’s Streamlined Guidelines

Biosimilars, Clinical trials, Drug development, EMA, FDA, Mabion, Regulatory

In-Process Testing for Drugs in the Pharmaceutical Industry

Analytics, Drug development

Role of Stable Cell Line in Biopharmaceutical Manufacturing 

Drug development, Drug product, Manufacturing

Time to Market Strategy – 5 CDMO Tactics to Speed Up Biologic Launches

Biologics, Drug development, Manufacturing